Pericarditis treatment: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}};'''Associate Editor-In-Chief:''' {{CZ}} | {{CMG}};'''Associate Editor-In-Chief:''' {{CZ}} | ||
The management of pericarditis depends upon whether the patient has an uncomplicated or a complicated disease course. | |||
==Management of Uncomplicated Pericarditis in the Absence of Significant Pericardial Effusion and Tamponade== | |||
Patients with uncomplicated acute pericarditis can generally be treated and followed up in an outpatient clinic. The treatment of viral or idiopathic pericarditis is with [[non-steroidal anti-inflammatory drug]]s. Patients should be observed for side effects since [[NSAID]]s are known to effect the GI mucosa. | |||
==Identification of High Risk or Complicated Pericarditis== | |||
Those with high risk factors for developing complications may required admission to an inpatient service for careful observation for hemodynamic compromise. High risk patients include:<!-- | |||
--><ref name="imazio2">{{cite journal | author= Imazio M, Demichelis B, Parrini I, Giuggia M, Cecchi E, Gaschino G, Demarie D, Ghisio A, Trinchero R | title= Day-hospital treatment of acute pericarditis: a management program for outpatient therapy | journal= J Am Coll Cardiol | year=2004 | pages=1042–6 | volume=43 | issue=6 | pmid=15028364 | doi= 10.1016/j.jacc.2003.09.055}}</ref> | --><ref name="imazio2">{{cite journal | author= Imazio M, Demichelis B, Parrini I, Giuggia M, Cecchi E, Gaschino G, Demarie D, Ghisio A, Trinchero R | title= Day-hospital treatment of acute pericarditis: a management program for outpatient therapy | journal= J Am Coll Cardiol | year=2004 | pages=1042–6 | volume=43 | issue=6 | pmid=15028364 | doi= 10.1016/j.jacc.2003.09.055}}</ref> | ||
* subacute onset | * subacute onset | ||
| Line 22: | Line 19: | ||
* acute trauma | * acute trauma | ||
* failure to respond to seven days of NSAID treatment. | * failure to respond to seven days of NSAID treatment. | ||
Severe cases of pericarditis may require: | |||
* [[pericardiocentesis]] | |||
* [[antibiotic]]s | |||
* [[steroid]]s | |||
* [[colchicine]] | |||
* [[surgery]] | |||
===Usual Steps in Treatment of Pericarditis=== | ===Usual Steps in Treatment of Pericarditis=== | ||
Revision as of 12:53, 25 June 2011
|
Pericarditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Surgery |
|
Case Studies |
|
Pericarditis treatment On the Web |
|
American Roentgen Ray Society Images of Pericarditis treatment |
|
Risk calculators and risk factors for Pericarditis treatment |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
The management of pericarditis depends upon whether the patient has an uncomplicated or a complicated disease course.
Management of Uncomplicated Pericarditis in the Absence of Significant Pericardial Effusion and Tamponade
Patients with uncomplicated acute pericarditis can generally be treated and followed up in an outpatient clinic. The treatment of viral or idiopathic pericarditis is with non-steroidal anti-inflammatory drugs. Patients should be observed for side effects since NSAIDs are known to effect the GI mucosa.
Identification of High Risk or Complicated Pericarditis
Those with high risk factors for developing complications may required admission to an inpatient service for careful observation for hemodynamic compromise. High risk patients include:[1]
- subacute onset
- high fever (> 100.4 F) and leukocytosis
- development of cardiac tamponade
- large pericardial effusion (echo-free space > 20 mm) resistant to NSAID treatment
- immunocompromised
- history of oral anticoagulation therapy
- acute trauma
- failure to respond to seven days of NSAID treatment.
Severe cases of pericarditis may require:
Usual Steps in Treatment of Pericarditis
Pericardiocentesis is a procedure whereby the fluid in a pericardial effusion is removed through a needle. It is performed under the following conditions:[2]
- presence of moderate or severe cardiac tamponade
- diagnostic purpose for suspected purulent, tuberculosis, or neoplastic pericarditis
- persistent symptomatic pericardial effusion
NSAIDs in viral or idiopathic pericarditis. In patients with underlying causes other than viral, the specific etiology should be treated. With idiopathic or viral pericarditis, NSAID is the mainstay treatment. Goal of therapy is to reduce pain and inflammation. The course of the disease may not be affected. The preferred NSAID is ibuprofen because of rare side effects, better effect on coronary flow, and larger dose range.[2] Depending on severity, dosing is between 300-800 mg every 6-8 hours for days or weeks as needed. An alternative protocol is aspirin 800 mg every 6-8 hours.[1] Dose tapering of NSAIDs may be needed. In pericarditis following acute myocardial infarction, NSAIDs other than aspirin should be avoided since they can impair scar formation. As with all NSAID use, GI protection should be engaged. Failure to respond to NSAIDs within one week (indicated by persistence of fever, worsening of condition, new pericardial effusion, or continuing chest pain) likely indicates that a cause other than viral or idiopathic is in process.
Colchicine can be used alone or in conjunction with NSAIDs in prevention of recurrent pericarditis and treatment of recurrent pericarditis. For patients with a first episode of acute idiopathic or viral pericarditis, they should be treated with an NSAID plus colchicine 2 mg on first day followed by 1 mg daily [3] for three months. [3][4][5]
Corticosteroids are usually used in those cases that are clearly refractory to NSAIDs and colchicine and a specific cause has not been found. Systemic corticosteroids are usually reserved for those with autoimmune disease.
References
- ↑ 1.0 1.1 Imazio M, Demichelis B, Parrini I, Giuggia M, Cecchi E, Gaschino G, Demarie D, Ghisio A, Trinchero R (2004). "Day-hospital treatment of acute pericarditis: a management program for outpatient therapy". J Am Coll Cardiol. 43 (6): 1042–6. doi:10.1016/j.jacc.2003.09.055. PMID 15028364.
- ↑ 2.0 2.1 Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH (2004). "Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology". Eur Heart J. 25 (7): 587–10. doi:10.1016/j.ehj.2004.02.002. PMID 15120056.
- ↑ Adler Y, Zandman-Goddard G, Ravid M, Avidan B, Zemer D, Ehrenfeld M, Shemesh J, Tomer Y, Shoenfeld Y (1994). "Usefulness of colchicine in preventing recurrences of pericarditis". Am J of Cardiol. 73 (12): 916–7. doi:10.1016/0002-9149(94)90828-1. PMID 8184826.
- ↑ Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, Moratti M, Gaschino G, Giammaria M, Ghisio A, Belli R, Trinchero R (2005). "Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial". Circulation. 112 (13): 2012–6. doi:10.1161/CIRCULATIONAHA.105.542738. PMID 16186437.
- ↑ Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M, Ghisio A, Belli R, Trinchero R (2005). "Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial". Arch Intern Med. 165 (17): 1987–91. doi:10.1001/archinte.165.17.1987. PMID 16186468.
de:Perikarditis nl:Pericarditis sv:Hjärtsäcksinflammation